Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review.

D'Anna R, Santamaria A, Alibrandi A, Corrado F, DI Benedetto A, Facchinetti F.

J Nutr Sci Vitaminol (Tokyo). 2019;65(Supplement):S59-S61. doi: 10.3177/jnsv.65.S59.

2.

Maternal peripheral blood CD34+ cells for prediction of fetal kidney malformations: results from a case-control analysis.

Giordano D, Cernaro V, Scilipoti M, Cosentino S, Inferrera R, Fresta J, Andreucci M, Conti G, Buemi M, D'Anna R, Coppolino G.

J Matern Fetal Neonatal Med. 2019 Jul 29:1-4. doi: 10.1080/14767058.2019.1645828. [Epub ahead of print]

PMID:
31315488
3.

Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials.

Laganà AS, Vitagliano A, Noventa M, Ambrosini G, D'Anna R.

Arch Gynecol Obstet. 2018 Oct;298(4):675-684. doi: 10.1007/s00404-018-4861-y. Epub 2018 Aug 4.

PMID:
30078122
4.

Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria.

Corrado F, Giunta L, Granese R, Corrado S, Micali M, Santamaria A, D'Anna R, Di Benedetto A.

J Matern Fetal Neonatal Med. 2019 Jan;32(2):225-228. doi: 10.1080/14767058.2017.1377175. Epub 2017 Sep 19.

PMID:
28877616
5.

Dietary Management of Skin Health: The Role of Genistein.

Irrera N, Pizzino G, D'Anna R, Vaccaro M, Arcoraci V, Squadrito F, Altavilla D, Bitto A.

Nutrients. 2017 Jun 17;9(6). pii: E622. doi: 10.3390/nu9060622. Review.

6.

The Impact of Kidney Development on the Life Course: A Consensus Document for Action.

Low Birth Weight and Nephron Number Working Group.

Nephron. 2017;136(1):3-49. doi: 10.1159/000457967. Epub 2017 Mar 21.

7.

A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group.

Luyckx VA, Perico N, Somaschini M, Manfellotto D, Valensise H, Cetin I, Simeoni U, Allegaert K, Vikse BE, Steegers EA, Adu D, Montini G, Remuzzi G, Brenner BM; writing group of the Low Birth Weight and Nephron Number Working Group.

Lancet. 2017 Jul 22;390(10092):424-428. doi: 10.1016/S0140-6736(17)30576-7. Epub 2017 Mar 9. No abstract available.

8.

miRNA expression for early diagnosis of preeclampsia onset: hope or hype?

Laganà AS, Vitale SG, Sapia F, Valenti G, Corrado F, Padula F, Rapisarda AMC, D'Anna R.

J Matern Fetal Neonatal Med. 2018 Mar;31(6):817-821. doi: 10.1080/14767058.2017.1296426. Epub 2017 Mar 5. Review.

PMID:
28282763
9.

Decreased Endothelial Progenitor Cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis.

Laganà AS, Giordano D, Loddo S, Zoccali G, Vitale SG, Santamaria A, Buemi M, D'Anna R.

Arch Gynecol Obstet. 2017 Apr;295(4):867-872. doi: 10.1007/s00404-017-4296-x. Epub 2017 Feb 28.

PMID:
28243732
10.

Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial.

Arcoraci V, Atteritano M, Squadrito F, D'Anna R, Marini H, Santoro D, Minutoli L, Messina S, Altavilla D, Bitto A.

Nutrients. 2017 Feb 22;9(2). pii: E179. doi: 10.3390/nu9020179.

11.

Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.

Vitale SG, Laganà AS, Nigro A, La Rosa VL, Rossetti P, Rapisarda AM, La Vignera S, Condorelli RA, Corrado F, Buscema M, D'Anna R.

PPAR Res. 2016;2016:6517313. doi: 10.1155/2016/6517313. Epub 2016 Dec 28. Review.

12.

Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis.

Giordano D, Loddo S, Laganà AS, Coppolino G, Zoccali G, Di Benedetto A, Santamaria A, Buemi M, D'Anna R.

J Matern Fetal Neonatal Med. 2018 Jan;31(2):258-260. doi: 10.1080/14767058.2016.1277703. Epub 2017 Jan 23.

PMID:
28110587
13.

Myo-inositol and melatonin in the menopausal transition.

D'Anna R, Santamaria A, Giorgianni G, Vaiarelli A, Gullo G, Di Bari F, Benvenga S.

Gynecol Endocrinol. 2017 Apr;33(4):279-282. doi: 10.1080/09513590.2016.1254613. Epub 2016 Dec 2.

PMID:
27910708
14.

Visfatin correlates with hot flashes in postmenopausal women with metabolic syndrome: effects of genistein.

Bitto A, Arcoraci V, Alibrandi A, D'Anna R, Corrado F, Atteritano M, Minutoli L, Altavilla D, Squadrito F.

Endocrine. 2017 Mar;55(3):899-906. doi: 10.1007/s12020-016-0968-8. Epub 2016 Apr 28.

PMID:
27126198
15.

Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.

Santamaria A, Di Benedetto A, Petrella E, Pintaudi B, Corrado F, D'Anna R, Neri I, Facchinetti F.

J Matern Fetal Neonatal Med. 2016 Oct;29(19):3234-7. doi: 10.3109/14767058.2015.1121478. Epub 2015 Dec 23.

PMID:
26698911
16.

Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.

Facchinetti F, Bizzarri M, Benvenga S, D'Anna R, Lanzone A, Soulage C, Di Renzo GC, Hod M, Cavalli P, Chiu TT, Kamenov ZA, Bevilacqua A, Carlomagno G, Gerli S, Oliva MM, Devroey P.

Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:72-6. doi: 10.1016/j.ejogrb.2015.09.024. Epub 2015 Oct 3.

PMID:
26479434
17.

Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension.

Santamaria A, Corrado F, Baviera G, Carlomagno G, Unfer V, D'anna R.

J Matern Fetal Neonatal Med. 2016;29(14):2245-7. doi: 10.3109/14767058.2015.1081886. Epub 2015 Sep 12.

PMID:
26364618
18.

Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.

DʼAnna R, Di Benedetto A, Scilipoti A, Santamaria A, Interdonato ML, Petrella E, Neri I, Pintaudi B, Corrado F, Facchinetti F.

Obstet Gynecol. 2015 Aug;126(2):310-5. doi: 10.1097/AOG.0000000000000958.

PMID:
26241420
19.

Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study.

Lello S, Sorge R, Surico N; OMERO Study Group.

Gynecol Endocrinol. 2015;31(12):992-8. doi: 10.3109/09513590.2015.1063605. Epub 2015 Jul 14.

PMID:
26172928
20.

Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology--assisted reproduction technology.

Bevilacqua A, Carlomagno G, Gerli S, Montanino Oliva M, Devroey P, Lanzone A, Soulange C, Facchinetti F, Carlo Di Renzo G, Bizzarri M, Hod M, Cavalli P, D'Anna R, Benvenga S, Chiu TT, Kamenov ZA.

Gynecol Endocrinol. 2015 Jun;31(6):441-6. doi: 10.3109/09513590.2015.1006616. Epub 2015 Jun 2. Review.

PMID:
26036719

Supplemental Content

Loading ...
Support Center